Apolipoprotein modulation of streptococcal serum opacity factor activity against human plasma high-density lipoproteins

Corina Rosales, Baiba K. Gillard, Harry Courtney, Francisco Blanco-Vaca, Henry J. Pownall

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Human plasma HDL are the target of streptococcal serum opacity factor (SOF), a virulence factor that clouds human plasma. Recombinant (r) SOF transfers cholesteryl esters (CE) from ∼400000 HDL particles to a CE-rich microemulsion (CERM), forms a cholesterol-poor HDL-like particle (neo HDL), and releases lipid-free (LF) apo A-I. Whereas the rSOF reaction requires labile apo A-I, the modulation effects of other apos are not known. Wecompared the products and rates of the rSO Freaction against human HDL and HDL from mice overexpressing apos A-I and A-II. Kinetic studies showed that the reactivity of various HDL species is apo-specific. LpA-I reacts faster than LpA-I/A-II. Adding apos A-I and A-II inhibited the SOF reaction, an effect that was more profound for apo A-II. The rate of SOF-mediated CERM formation was slower against HDL from mice expressing human apos A-I and A-II than against WT mice HDL and slowest against HDL from apo A-II overexpressing mice. The lower reactivity of SOF against HDL containing human apos is due to the higher hydropathy of human apo A-I, particularly its C-terminus relative to mouse apo A-I, and the higher lipophilicity of human apo A-II. The SOF-catalyzed reaction is the first to target HDL rather than its transporters and receptors in a way that enhances reverse cholesterol transport (RCT). Thus, effects of apos on the SOF reaction are highly relevant. Our studies show that the "humanized" apo A-Iexpressing mouse is a good animal model for studies of rSOF effects on RCT in vivo.

Original languageEnglish (US)
Pages (from-to)8070-8076
Number of pages7
JournalBiochemistry
Volume48
Issue number33
DOIs
StatePublished - Aug 25 2009

Fingerprint

Plasma (human)
Apolipoproteins
HDL Lipoproteins
Human Activities
Modulation
Apolipoprotein A-I
Apolipoprotein A-II
Cholesterol
Microemulsions
Apolipoproteins A
Cholesterol Esters
Virulence Factors
opacity factor
HDL Cholesterol
Animals
Animal Models
Lipids
Kinetics

All Science Journal Classification (ASJC) codes

  • Biochemistry

Cite this

Apolipoprotein modulation of streptococcal serum opacity factor activity against human plasma high-density lipoproteins. / Rosales, Corina; Gillard, Baiba K.; Courtney, Harry; Blanco-Vaca, Francisco; Pownall, Henry J.

In: Biochemistry, Vol. 48, No. 33, 25.08.2009, p. 8070-8076.

Research output: Contribution to journalArticle

Rosales, C, Gillard, BK, Courtney, H, Blanco-Vaca, F & Pownall, HJ 2009, 'Apolipoprotein modulation of streptococcal serum opacity factor activity against human plasma high-density lipoproteins', Biochemistry, vol. 48, no. 33, pp. 8070-8076. https://doi.org/10.1021/bi901087z
Rosales, Corina ; Gillard, Baiba K. ; Courtney, Harry ; Blanco-Vaca, Francisco ; Pownall, Henry J. / Apolipoprotein modulation of streptococcal serum opacity factor activity against human plasma high-density lipoproteins. In: Biochemistry. 2009 ; Vol. 48, No. 33. pp. 8070-8076.
@article{a92a8ed8eccd44f89b819dcca516c4d3,
title = "Apolipoprotein modulation of streptococcal serum opacity factor activity against human plasma high-density lipoproteins",
abstract = "Human plasma HDL are the target of streptococcal serum opacity factor (SOF), a virulence factor that clouds human plasma. Recombinant (r) SOF transfers cholesteryl esters (CE) from ∼400000 HDL particles to a CE-rich microemulsion (CERM), forms a cholesterol-poor HDL-like particle (neo HDL), and releases lipid-free (LF) apo A-I. Whereas the rSOF reaction requires labile apo A-I, the modulation effects of other apos are not known. Wecompared the products and rates of the rSO Freaction against human HDL and HDL from mice overexpressing apos A-I and A-II. Kinetic studies showed that the reactivity of various HDL species is apo-specific. LpA-I reacts faster than LpA-I/A-II. Adding apos A-I and A-II inhibited the SOF reaction, an effect that was more profound for apo A-II. The rate of SOF-mediated CERM formation was slower against HDL from mice expressing human apos A-I and A-II than against WT mice HDL and slowest against HDL from apo A-II overexpressing mice. The lower reactivity of SOF against HDL containing human apos is due to the higher hydropathy of human apo A-I, particularly its C-terminus relative to mouse apo A-I, and the higher lipophilicity of human apo A-II. The SOF-catalyzed reaction is the first to target HDL rather than its transporters and receptors in a way that enhances reverse cholesterol transport (RCT). Thus, effects of apos on the SOF reaction are highly relevant. Our studies show that the {"}humanized{"} apo A-Iexpressing mouse is a good animal model for studies of rSOF effects on RCT in vivo.",
author = "Corina Rosales and Gillard, {Baiba K.} and Harry Courtney and Francisco Blanco-Vaca and Pownall, {Henry J.}",
year = "2009",
month = "8",
day = "25",
doi = "10.1021/bi901087z",
language = "English (US)",
volume = "48",
pages = "8070--8076",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "33",

}

TY - JOUR

T1 - Apolipoprotein modulation of streptococcal serum opacity factor activity against human plasma high-density lipoproteins

AU - Rosales, Corina

AU - Gillard, Baiba K.

AU - Courtney, Harry

AU - Blanco-Vaca, Francisco

AU - Pownall, Henry J.

PY - 2009/8/25

Y1 - 2009/8/25

N2 - Human plasma HDL are the target of streptococcal serum opacity factor (SOF), a virulence factor that clouds human plasma. Recombinant (r) SOF transfers cholesteryl esters (CE) from ∼400000 HDL particles to a CE-rich microemulsion (CERM), forms a cholesterol-poor HDL-like particle (neo HDL), and releases lipid-free (LF) apo A-I. Whereas the rSOF reaction requires labile apo A-I, the modulation effects of other apos are not known. Wecompared the products and rates of the rSO Freaction against human HDL and HDL from mice overexpressing apos A-I and A-II. Kinetic studies showed that the reactivity of various HDL species is apo-specific. LpA-I reacts faster than LpA-I/A-II. Adding apos A-I and A-II inhibited the SOF reaction, an effect that was more profound for apo A-II. The rate of SOF-mediated CERM formation was slower against HDL from mice expressing human apos A-I and A-II than against WT mice HDL and slowest against HDL from apo A-II overexpressing mice. The lower reactivity of SOF against HDL containing human apos is due to the higher hydropathy of human apo A-I, particularly its C-terminus relative to mouse apo A-I, and the higher lipophilicity of human apo A-II. The SOF-catalyzed reaction is the first to target HDL rather than its transporters and receptors in a way that enhances reverse cholesterol transport (RCT). Thus, effects of apos on the SOF reaction are highly relevant. Our studies show that the "humanized" apo A-Iexpressing mouse is a good animal model for studies of rSOF effects on RCT in vivo.

AB - Human plasma HDL are the target of streptococcal serum opacity factor (SOF), a virulence factor that clouds human plasma. Recombinant (r) SOF transfers cholesteryl esters (CE) from ∼400000 HDL particles to a CE-rich microemulsion (CERM), forms a cholesterol-poor HDL-like particle (neo HDL), and releases lipid-free (LF) apo A-I. Whereas the rSOF reaction requires labile apo A-I, the modulation effects of other apos are not known. Wecompared the products and rates of the rSO Freaction against human HDL and HDL from mice overexpressing apos A-I and A-II. Kinetic studies showed that the reactivity of various HDL species is apo-specific. LpA-I reacts faster than LpA-I/A-II. Adding apos A-I and A-II inhibited the SOF reaction, an effect that was more profound for apo A-II. The rate of SOF-mediated CERM formation was slower against HDL from mice expressing human apos A-I and A-II than against WT mice HDL and slowest against HDL from apo A-II overexpressing mice. The lower reactivity of SOF against HDL containing human apos is due to the higher hydropathy of human apo A-I, particularly its C-terminus relative to mouse apo A-I, and the higher lipophilicity of human apo A-II. The SOF-catalyzed reaction is the first to target HDL rather than its transporters and receptors in a way that enhances reverse cholesterol transport (RCT). Thus, effects of apos on the SOF reaction are highly relevant. Our studies show that the "humanized" apo A-Iexpressing mouse is a good animal model for studies of rSOF effects on RCT in vivo.

UR - http://www.scopus.com/inward/record.url?scp=69049092124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69049092124&partnerID=8YFLogxK

U2 - 10.1021/bi901087z

DO - 10.1021/bi901087z

M3 - Article

VL - 48

SP - 8070

EP - 8076

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 33

ER -